These seemingly discrepant results raise important questions regarding the mechanisms through which Myh14 deficiency leads to cardiomyocyte death in the absence of mechanotransduction stress in vitro and cardiac hypertrophy on an organ level in vivo. Here, MYH14 is linked to cardiac hypertrophy.